A new imaging test to find returning cancer
Treatments studied
Part of Cancer, Digestive system, Lungs & breathing, Skin clinical trials.
This trial tests a new imaging agent that helps find cancer cells that have come back. It is given as an injection and then a scan is done to see if it helps doctors locate the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old and feel well enough to do daily activities (ECOG score 0 or 1).
- You must have a confirmed solid tumor (like lung, cervical, melanoma, breast, or gastrointestinal) that has either recently come back or is suspected to have come back.
- You need at least one tumor that can be measured on a scan, like a CT or MRI.
- You must be expected to live at least 12 more weeks.
- You need normal blood counts and liver/kidney function, as checked by your doctor.
- Women must use effective birth control during the study and for 6 months after; men must use contraception for the same period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a new radioactive tracer that attaches to a protein found on many solid tumors, allowing doctors to see tumors on a PET scan. It may help improve how tumors are detected and monitored.
This study uses a special scan (molecular imaging) to see how well antibody-drug conjugates (ADCs) work in people with breast cancer. It may help doctors choose the right treatment for you.
This study tests a new imaging method to see if a special 'tracer' can light up tumors that have a protein called PD-L1, which is a target for immunotherapy. By taking a PET scan, doctors hope to predict whether immunotherapy will work for you.
This trial tests a new imaging method that uses a radioactive tracer to find HER2-positive cancer cells in the body. It may help doctors see tumors more clearly in people with stomach, breast, or bladder cancer.
This trial uses a special PET/CT scan to find breast cancer cells that have a certain marker (CD73). It may help doctors see the cancer more clearly before you start other treatments.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.